Pro-Dex, Inc. last reported quarterly results on Oct 29, 2026, for Q1 FY2027 (the quarter ended Sep 30, 2026): revenue of $20.6 million (+11.0% year over year) and diluted EPS of $0.92. It usually reports 29–65 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 28, 2027.
Results for Q2 FY2027, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Jan 29, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 29–65 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
29 days after quarter end
|
Q1 FY2027
ended Sep 30, 2026
|
21
+11.0%
|
3
-34.9%
|
0.92
-34.3%
|
|
Sep 3, 2026
65 days after quarter end
|
Q4 FY2026
ended Jun 30, 2026
|
20
+16.6%
|
3
+138.7%
|
0.85
+137.6%
|
|
Apr 30, 2026
30 days after quarter end
|
Q3 FY2026
ended Mar 31, 2026
|
20
+14.6%
|
4
+20.2%
|
1.20
+22.4%
|
|
Jan 29, 2026
29 days after quarter end
|
Q2 FY2026
ended Dec 31, 2025
|
19
+11.1%
|
2
+7.2%
|
0.66
+8.2%
|
|
Oct 30, 2025
30 days after quarter end
|
Q1 FY2026
ended Sep 30, 2025
|
19
+24.4%
|
5
+89.8%
|
1.40
+86.7%
|
|
Sep 4, 2025
66 days after quarter end
|
Q4 FY2025
ended Jun 30, 2025
|
17
+16.4%
|
1
-24.6%
|
0.36
-21.7%
|
|
May 1, 2025
31 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
17
+21.8%
|
3
+400.0%
|
0.98
+415.8%
|
|
Jan 30, 2025
30 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
17
+33.4%
|
2
+308.0%
|
0.61
+335.7%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PDEX (Nasdaq)
- Fiscal year ends
- June 30
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 788920
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.